Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow in Gastroenterology, Medicine, Mayo School of Health Sciences 1995 - 1998
  • Medical Resident, Medicine, Mayo School of Health Sciences 1992 - 1995
  • M.D., University Missouri Kansas City 1992
• 

  Duke Appointment History

  • Associate Professor of Medicine, Medicine, Gastroenterology, Medicine 2014 - 2017
  • Associate Professor of Medicine, Medicine, Gastroenterology, Medicine 2006 - 2014
  • Instructor, Temporary in the Department of Medicine, Medicine, Gastroenterology, Medicine 2006
• Research
• 

  Selected Grants

  • Gilead 384-1943 awarded by Gilead Sciences, Inc. 2017 - 2025
  • Gilead 384-1944 awarded by Gilead Sciences, Inc. 2017 - 2025
  • Duke CTSA (KL2) awarded by National Institutes of Health 2018 - 2023
  • Duke CTSA (TL1) awarded by National Institutes of Health 2018 - 2023
  • Target-NASH awarded by TARGET PharmaSolutions, Inc. 2017 - 2023
  • Intercept 747-303 awarded by Intercept Pharmaceuticals, Inc 2015 - 2022
  • FALCON 1 awarded by Bristol-Myers Squibb Company 2018 - 2022
  • FALCON 2 awarded by Bristol-Myers Squibb Company 2018 - 2022
  • Inventiva IVA337 awarded by Inventiva 2019 - 2022
  • NGM282 18-0108 awarded by NGM Biopharmaceuticals, Inc. 2019 - 2022
  • Genfit GFT505-315-1 NASH awarded by GENFIT 2016 - 2022
  • Novartis LJC242A2201J awarded by Novartis Pharmaceuticals Corporation 2018 - 2021
  • Duke Training Grant in Digestive Diseases and Nutrition awarded by National Institutes of Health 1988 - 2021
  • Intercept 747-304 awarded by Intercept Pharmaceuticals, Inc 2017 - 2021
  • Galectin GI-026 awarded by Galectin Therapeutics, Inc. 2015 - 2021
  • Enyo EYP001-202 awarded by ENYO Pharma SA 2019 - 2021
  • Enanta EDP 305-101 awarded by Enanta Pharmaceuticals, Inc. 2018 - 2020
  • Madrigal MGL-3196-05 awarded by Madrigal Pharmaceuticals, Inc. 2016 - 2020
  • Gilead 454-4378 awarded by Gilead Sciences, Inc. 2018 - 2020
  • Boehringer BI 1467335 awarded by Boehringer Ingelheim Pharmaceuticals, Inc. 2017 - 2020
  • Gilead 384-1497 awarded by Gilead Sciences, Inc. 2015 - 2020
  • Genetic and Epigenetic Markers of Progressive Nonalcoholic Fatty Liver Disease awarded by American Association for the Study of Liver Diseases 2018 - 2019
  • Allergan 301-002 awarded by Allergan, Inc. 2017 - 2019
  • Allergan 201-002 awarded by Allergan, Inc. 2017 - 2019
  • Conatus IDN-6556-12 awarded by Conatus Pharmaceuticals 2015 - 2019
  • BMS MB130-045 awarded by Bristol-Myers Squibb Company 2015 - 2019
  • NGM 15-0105 awarded by NGM Biopharmaceuticals 2015 - 2019
  • Immuron IMM-124E awarded by Immuron, Ltd 2014 - 2019
  • Gilead 402-1852 awarded by Gilead Sciences, Inc. 2016 - 2019
  • Progenity PRO-121-NAFLD awarded by Progenity, Inc. 2017 - 2019
  • Conatus IDN 6556-14 awarded by Conatus Pharmaceuticals 2016 - 2019
  • Conatus IDN 6556-17 awarded by Conatus Pharmaceuticals 2017 - 2019
  • Shire SHP626-201 awarded by Shire Human Genetics Therapies 2016 - 2019
  • TOBIRA 652-2-203 awarded by Tobira Therapeutics, Inc 2014 - 2019
  • NASH Clinical Research Network awarded by National Institutes of Health 2004 - 2019
  • GILEAD 426-3989 awarded by Gilead Sciences, Inc. 2016 - 2019
  • Intercept 747-117 awarded by Intercept Pharmaceuticals, Inc 2018 - 2019
  • ARREST - GALMED awarded by Galmed Pharmaceuticals Ltd. 2015 - 2019
  • Intercept 747-209 awarded by Intercept Pharmaceuticals, Inc 2015 - 2019
  • Cirius EMMINENCE awarded by Cirius Therapeutics 2017 - 2018
  • Exalenz - CSPH-EX-0414 awarded by Exalenz Bioscience Ltd. 2016 - 2018
  • Glympse Bio NASH awarded by Glympse Bio, Inc. 2017
  • Acoustic Radiation Force Based Hepatic Elasticity Quantification and Imaging awarded by National Institutes of Health 2001 - 2017
  • ARI-3037MO-006 awarded by Arisaph Pharmaceuticals, Inc. 2015 - 2017
  • Impact of Fructose on Metabolism, Energy Homeostasis and MR biomarkers in NAFLD awarded by National Institutes of Health 2012 - 2016
  • Synageva BioPharma LAL-CSS01 awarded by Synageva BioPharma 2014 - 2016
  • Development and clinical validation of a clinical diagnostic/prognostic laboratory test for liver disease awarded by Metabolon, Inc. 2014 - 2016
  • Characterizing Alcohol's Effects on Repair of Liver Injury awarded by National Institutes of Health 2009 - 2012
  • Hyperinsulimia and Insulin Resistance in Nonalcoholic Fatty Liver Disease awarded by National Institutes of Health 2006 - 2010
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Sanyal, Arun, Edgar D. Charles, Brent A. Neuschwander-Tetri, Rohit Loomba, Stephen A. Harrison, Manal F. Abdelmalek, Eric J. Lawitz, et al. “Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial..” Lancet (London, England) 392, no. 10165 (December 2019): 2705–17. https://doi.org/10.1016/s0140-6736(18)31785-9.
       Full Text
    • Chalasani, Naga, Manal F. Abdelmalek, Rohit Loomba, Kris V. Kowdley, Arthur J. McCullough, Srinivasan Dasarathy, Brent A. Neuschwander-Tetri, et al. “Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis..” Liver Int 39, no. 5 (May 2019): 924–32. https://doi.org/10.1111/liv.13974.
       Full Text  Link to Item
    • Corey, Kathleen E., Laura A. Wilson, Akif Altinbas, Katherine P. Yates, David E. Kleiner, Raymond T. Chung, Ronald M. Krauss, Naga Chalasani, and Naga NASH Clinical Research Network. “Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial..” Aliment Pharmacol Ther 49, no. 9 (May 2019): 1205–13. https://doi.org/10.1111/apt.15216.
       Full Text  Link to Item
    • Sanyal, Arun J., Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Stephen Caldwell, Mitchell L. Shiffman, et al. “The Natural History of Advanced Fibrosis due to Nonalcoholic Steatohepatitis: Data from the Simtuzumab Trials..” Hepatology, April 16, 2019. https://doi.org/10.1002/hep.30664.
       Full Text  Link to Item
    • Rinella, Mary E., James F. Trotter, Manal F. Abdelmalek, Angelo H. Paredes, Margery A. Connelly, Mark J. Jaros, Lei Ling, Stephen J. Rossi, Alex M. DePaoli, and Stephen A. Harrison. “Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis..” Journal of Hepatology 70, no. 4 (April 2019): 735–44. https://doi.org/10.1016/j.jhep.2018.11.032.
       Full Text
    • Lonardo, Amedeo, Fabio Nascimbeni, Stefano Ballestri, DeLisa Fairweather, Sanda Win, Tin A. Than, Manal F. Abdelmalek, and Ayako Suzuki. “Sex Differences in NAFLD: State of the Art and Identification of Research Gaps..” Hepatology (Baltimore, Md.), March 29, 2019. https://doi.org/10.1002/hep.30626.
       Full Text
    • Jayakumar, Saumya, Michael S. Middleton, Eric J. Lawitz, Parvez S. Mantry, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, et al. “Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib..” Journal of Hepatology 70, no. 1 (January 2019): 133–41. https://doi.org/10.1016/j.jhep.2018.09.024.
       Full Text
    • Loomba, Rohit, Arun J. Sanyal, Kris V. Kowdley, Norah Terrault, Naga P. Chalasani, Manal F. Abdelmalek, Arthur J. McCullough, et al. “Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis..” Gastroenterology 156, no. 1 (January 2019): 88-95.e5. https://doi.org/10.1053/j.gastro.2018.09.021.
       Full Text
    • Siddiqui, Mohammad S., Raj Vuppalanchi, Mark L. Van Natta, Erin Hallinan, Kris V. Kowdley, Manal Abdelmalek, Brent A. Neuschwander-Tetri, et al. “Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease..” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 17, no. 1 (January 2019): 156-163.e2. https://doi.org/10.1016/j.cgh.2018.04.043.
       Full Text
    • Younossi, Zobair, Maria Stepanova, Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, et al. “The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options..” Journal of Hepatology 69, no. 6 (December 2018): 1365–70. https://doi.org/10.1016/j.jhep.2018.08.013.
       Full Text
    • Loomba, Rohit, Anjali Jain, Anna Mae Diehl, Cynthia D. Guy, Dana Portenier, Ranjan Sudan, Seema Singh, et al. “Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis..” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, November 15, 2018. https://doi.org/10.1016/j.cgh.2018.11.004.
       Full Text
    • Glass, Oliver, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing-Kin Syn, Cynthia A. Moylan, et al. “Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease..” Hepatology Communications 2, no. 11 (November 2018): 1344–55. https://doi.org/10.1002/hep4.1237.
       Full Text
    • Wildman-Tobriner, Benjamin, Michael M. Middleton, Cynthia A. Moylan, Stephen Rossi, Omar Flores, Zac Anchi Chang, Manal F. Abdelmalek, Claude B. Sirlin, and Mustafa R. Bashir. “Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis..” Gastroenterology 155, no. 5 (November 2018): 1428-1435.e2. https://doi.org/10.1053/j.gastro.2018.07.018.
       Full Text
    • Harrison, Stephen A., Manal F. Abdelmalek, Stephen Caldwell, Mitchell L. Shiffman, Anna Mae Diehl, Reem Ghalib, Eric J. Lawitz, et al. “Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis..” Gastroenterology 155, no. 4 (October 2018): 1140–53. https://doi.org/10.1053/j.gastro.2018.07.006.
       Full Text
    • Moylan, Cynthia A., and Manal F. Abdelmalek. “Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis..” Hepatology (Baltimore, Md.) 68, no. 4 (October 2018): 1646–48. https://doi.org/10.1002/hep.29879.
       Full Text
    • Yang, J. D., M. F. Abdelmalek, C. D. Guy, A. M. Diehl, and A. Suzuki. “Reply.” Clinical Gastroenterology and Hepatology 16, no. 10 (October 1, 2018). https://doi.org/10.1016/j.cgh.2017.05.003.
       Full Text  Open Access Copy
    • Yang, Ju Dong, Manal F. Abdelmalek, Cynthia D. Guy, Anna Mae Diehl, and Ayako Suzuki. “Reply..” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 16, no. 10 (October 2018). https://doi.org/10.1016/j.cgh.2017.05.003.
       Full Text
    • Kleinstein, Sarah E., Matthew Rein, Manal F. Abdelmalek, Cynthia D. Guy, David B. Goldstein, Anna Mae Diehl, and Cynthia A. Moylan. “Whole-Exome Sequencing Study of Extreme Phenotypes of NAFLD..” Hepatology Communications 2, no. 9 (September 5, 2018): 1021–29. https://doi.org/10.1002/hep4.1227.
       Full Text
    • Younossi, Zobair M., Rohit Loomba, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander-Tetri, Lawrence Serfaty, et al. “Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis..” Hepatology (Baltimore, Md.) 68, no. 1 (July 2018): 361–71. https://doi.org/10.1002/hep.29724.
       Full Text
    • Younossi, Zobair M., Rohit Loomba, Quentin M. Anstee, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander-Tetri, et al. “Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis..” Hepatology (Baltimore, Md.) 68, no. 1 (July 2018): 349–60. https://doi.org/10.1002/hep.29721.
       Full Text
    • Friedman, Scott L., Vlad Ratziu, Stephen A. Harrison, Manal F. Abdelmalek, Guruprasad P. Aithal, Juan Caballeria, Sven Francque, et al. “A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis..” Hepatology 67, no. 5 (May 2018): 1754–67. https://doi.org/10.1002/hep.29477.
       Full Text  Link to Item
    • Jensen, Thomas, Manal F. Abdelmalek, Shelby Sullivan, Kristen J. Nadeau, Melanie Green, Carlos Roncal, Takahiko Nakagawa, et al. “Fructose and sugar: A major mediator of non-alcoholic fatty liver disease..” J Hepatol 68, no. 5 (May 2018): 1063–75. https://doi.org/10.1016/j.jhep.2018.01.019.
       Full Text  Link to Item
    • Siddiqui, Mohammad Shadab, Stephen A. Harrison, Manal F. Abdelmalek, Quentin M. Anstee, Pierre Bedossa, Laurent Castera, Lara Dimick-Santos, et al. “Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science..” Hepatology (Baltimore, Md.) 67, no. 5 (May 2018): 2001–12. https://doi.org/10.1002/hep.29607.
       Full Text
    • Harrison, Stephen A., Mary E. Rinella, Manal F. Abdelmalek, James F. Trotter, Angelo H. Paredes, Hays L. Arnold, Marcelo Kugelmas, et al. “NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial..” Lancet 391, no. 10126 (March 24, 2018): 1174–85. https://doi.org/10.1016/S0140-6736(18)30474-4.
       Full Text  Link to Item
    • Vuppalanchi, Raj, Mohammad S. Siddiqui, Mark L. Van Natta, Erin Hallinan, Danielle Brandman, Kris Kowdley, Brent A. Neuschwander-Tetri, et al. “Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease..” Hepatology (Baltimore, Md.) 67, no. 1 (January 2018): 134–44. https://doi.org/10.1002/hep.29489.
       Full Text
    • Wegermann, Kara, Ricardo Henao, Anna Mae Diehl, Susan K. Murphy, Manal F. Abdelmalek, and Cynthia A. Moylan. “Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study..” Plos One 13, no. 9 (January 2018). https://doi.org/10.1371/journal.pone.0204308.
       Full Text
    • Glass, O. K., A. Radia, W. E. Kraus, and M. F. Abdelmalek. “Exercise training as treatment of nonalcoholic fatty liver disease.” Journal of Functional Morphology and Kinesiology 2, no. 4 (December 1, 2017). https://doi.org/10.3390/jfmk2040035.
       Full Text
    • Newton, Kimberly P., Haruna S. Feldman, Christina D. Chambers, Laura Wilson, Cynthia Behling, Jeanne M. Clark, Jean P. Molleston, et al. “Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children..” The Journal of Pediatrics 187 (August 2017): 141-146.e1. https://doi.org/10.1016/j.jpeds.2017.03.007.
       Full Text
    • Kappus, Matthew, and Manal Abdelmalek. “De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation..” Clinics in Liver Disease 21, no. 2 (May 2017): 321–35. https://doi.org/10.1016/j.cld.2016.12.006.
       Full Text
    • Patel, Yuval A., Ricardo Henao, Cynthia A. Moylan, Cynthia D. Guy, Dawn L. Piercy, Anna Mae Diehl, and Manal F. Abdelmalek. “Reply to Kim et al..” The American Journal of Gastroenterology 112, no. 5 (May 2017): 807–8. https://doi.org/10.1038/ajg.2017.45.
       Full Text
    • Yang, Ju Dong, Manal F. Abdelmalek, Cynthia D. Guy, Ryan M. Gill, Joel E. Lavine, Katherine Yates, Jagpal Klair, et al. “Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis..” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 15, no. 1 (January 2017): 127-131.e2. https://doi.org/10.1016/j.cgh.2016.07.034.
       Full Text
    • Abdelmalek, Manal F. “NAFLD: The clinical and economic burden of NAFLD: time to turn the tide..” Nature Reviews. Gastroenterology & Hepatology 13, no. 12 (December 2016): 685–86. https://doi.org/10.1038/nrgastro.2016.178.
       Full Text
    • Nelson, J. E., P. Handa, B. Aouizerat, L. Wilson, L. A. Vemulakonda, M. M. Yeh, K. V. Kowdley, and K. V. NASH Clinical Research Network. “Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms..” Alimentary Pharmacology & Therapeutics 44, no. 11–12 (December 2016): 1253–64. https://doi.org/10.1111/apt.13824.
       Full Text
    • Patel, Yuval A., Ricardo Henao, Cynthia A. Moylan, Cynthia D. Guy, Dawn L. Piercy, Anna Mae Diehl, and Manal F. Abdelmalek. “Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis..” The American Journal of Gastroenterology 111, no. 11 (November 2016): 1591–98. https://doi.org/10.1038/ajg.2016.406.
       Full Text
    • Klair, Jagpal Singh, Ju Dong Yang, Manal F. Abdelmalek, Cynthia D. Guy, Ryan M. Gill, Katherine Yates, Aynur Unalp-Arida, et al. “A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease..” Hepatology (Baltimore, Md.) 64, no. 1 (July 2016): 85–91. https://doi.org/10.1002/hep.28514.
       Full Text
    • Ratziu, Vlad, Stephen A. Harrison, Sven Francque, Pierre Bedossa, Philippe Lehert, Lawrence Serfaty, Manuel Romero-Gomez, et al. “Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening..” Gastroenterology 150, no. 5 (May 2016): 1147-1159.e5. https://doi.org/10.1053/j.gastro.2016.01.038.
       Full Text
    • Thrasher, Tyler, and Manal F. Abdelmalek. “Nonalcoholic Fatty Liver Disease..” North Carolina Medical Journal 77, no. 3 (May 2016): 216–19. https://doi.org/10.18043/ncm.77.3.216.
       Full Text
    • Zhu, Ruixin, Susan S. Baker, Cynthia A. Moylan, Manal F. Abdelmalek, Cynthia D. Guy, Fausto Zamboni, Dingfeng Wu, et al. “Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers..” The Journal of Pathology 238, no. 4 (March 2016): 531–42. https://doi.org/10.1002/path.4650.
       Full Text
    • Abdelmalek, Manal F., and Chris Day. “Sugar sweetened beverages and fatty liver disease: Rising concern and call to action..” Journal of Hepatology 63, no. 2 (August 2015): 306–8. https://doi.org/10.1016/j.jhep.2015.05.021.
       Full Text
    • Deng, Yufeng, Mark L. Palmeri, Ned C. Rouze, Stephen J. Rosenzweig, Manal F. Abdelmalek, and Kathryn R. Nightingale. “Analyzing the Impact of Increasing Mechanical Index and Energy Deposition on Shear Wave Speed Reconstruction in Human Liver..” Ultrasound in Medicine & Biology 41, no. 7 (July 2015): 1948–57. https://doi.org/10.1016/j.ultrasmedbio.2015.02.019.
       Full Text
    • Guy, C., A. Suzuki, M. Abdelmalek, J. Burchette, and A. M. Diehl. “Reply.” Hepatology 61, no. 5 (May 1, 2015): 1770–71. https://doi.org/10.1002/hep.27430.
       Full Text
    • Neuschwander-Tetri, Brent A., Rohit Loomba, Arun J. Sanyal, Joel E. Lavine, Mark L. Van Natta, Manal F. Abdelmalek, Naga Chalasani, et al. “Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial..” Lancet (London, England) 385, no. 9972 (March 2015): 956–65. https://doi.org/10.1016/S0140-6736(14)61933-4.
       Full Text
    • Guy, C. D., A. Suzuki, M. F. Abdelmalek, J. L. Burchette, and A. M. Diehl. “Treatment response in the PIVENS trial is associated with decreased hedgehog pathway activity.” Hepatology 61, no. 1 (January 1, 2015): 98–107. https://doi.org/10.1002/hep.27235.
       Full Text
    • Guy, Cynthia D., Ayako Suzuki, Manal F. Abdelmalek, James L. Burchette, Anna Mae Diehl, and Anna Mae NASH CRN. “Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity..” Hepatology (Baltimore, Md.) 61, no. 1 (January 2015): 98–107. https://doi.org/10.1002/hep.27235.
       Full Text
    • Nightingale, Kathryn R., Ned C. Rouze, Stephen J. Rosenzweig, Michael H. Wang, Manal F. Abdelmalek, Cynthia D. Guy, and Mark L. Palmeri. “Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging..” Ieee Trans Ultrason Ferroelectr Freq Control 62, no. 1 (January 2015): 165–75. https://doi.org/10.1109/TUFFC.2014.006653.
       Full Text  Link to Item
    • Bohinc, Brittany N., Gregory Michelotti, Guanhua Xie, Herbert Pang, Ayako Suzuki, Cynthia D. Guy, Dawn Piercy, et al. “Repair-related activation of hedgehog signaling in stromal cells promotes intrahepatic hypothyroidism..” Endocrinology 155, no. 11 (November 2014): 4591–4601. https://doi.org/10.1210/en.2014-1302.
       Full Text  Link to Item
    • Sanyal, Arun J., Manal F. Abdelmalek, Ayako Suzuki, Oscar W. Cummings, Mario Chojkier, and Mario EPE-A Study Group. “No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial..” Gastroenterology 147, no. 2 (August 2014): 377-84.e1. https://doi.org/10.1053/j.gastro.2014.04.046.
       Full Text
    • Siddique, Asma, James E. Nelson, Bradley Aouizerat, Matthew M. Yeh, Kris V. Kowdley, and Kris V. NASH Clinical Research Network. “Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin..” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 12, no. 7 (July 2014): 1170–78. https://doi.org/10.1016/j.cgh.2013.11.017.
       Full Text
    • Gadd, Victoria L., Richard Skoien, Elizabeth E. Powell, Kevin J. Fagan, Clay Winterford, Leigh Horsfall, Katharine Irvine, and Andrew D. Clouston. “The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease.” Hepatology 59, no. 4 (April 2014): 1393–1405. https://doi.org/10.1002/hep.26937.
       Full Text
    • Moylan, Cynthia A., Herbert Pang, Andrew Dellinger, Ayako Suzuki, Melanie E. Garrett, Cynthia D. Guy, Susan K. Murphy, et al. “Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease..” Hepatology 59, no. 2 (February 2014): 471–82. https://doi.org/10.1002/hep.26661.
       Full Text  Link to Item
    • Yang, J. D., M. F. Abdelmalek, H. Pang, C. D. Guy, A. D. Smith, A. M. Diehl, and A. Suzuki. “Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.” Hepatology 59, no. 4 (January 1, 2014): 1406–14. https://doi.org/10.1002/hep.26761.
       Full Text
    • Sanyal, Arun J., Manal F. Abdelmalek, Ayako Suzuki, Oscar Cummings, and Mario Chojkier. “A Phase 2B Double-Blind Placebo Controlled Study of Two Doses of EPA-E in Patients With Nonalcoholic Steatohepatitis.” Hepatology 58, no. 6 (December 1, 2013): 1385A-1385A.
       Link to Item
    • Ishimoto, T., M. A. Lanaspa, C. J. Rivard, C. A. Roncal-Jimenez, D. J. Orlicky, C. Cicerchi, R. H. Mcmahan, et al. “High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase.” Hepatology 58, no. 5 (November 1, 2013): 1632–43. https://doi.org/10.1002/hep.26594.
       Full Text
    • Ishimoto, Takuji, Miguel A. Lanaspa, Christopher J. Rivard, Carlos A. Roncal-Jimenez, David J. Orlicky, Christina Cicerchi, Rachel H. McMahan, et al. “High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase..” Hepatology 58, no. 5 (November 2013): 1632–43. https://doi.org/10.1002/hep.26594.
       Full Text  Link to Item
    • Murphy, Susan K., Hyuna Yang, Cynthia A. Moylan, Herbert Pang, Andrew Dellinger, Manal F. Abdelmalek, Melanie E. Garrett, et al. “Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease..” Gastroenterology 145, no. 5 (November 2013): 1076–87. https://doi.org/10.1053/j.gastro.2013.07.047.
       Full Text  Link to Item
    • Youssef, Nagy A., Manal F. Abdelmalek, Martin Binks, Cynthia D. Guy, Alessia Omenetti, Alastair D. Smith, Anna Mae E. Diehl, and Ayako Suzuki. “Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease..” Liver International : Official Journal of the International Association for the Study of the Liver 33, no. 7 (August 2013): 1062–70. https://doi.org/10.1111/liv.12165.
       Full Text
    • Swiderska-Syn, Marzena, Ayako Suzuki, Cynthia D. Guy, Jeffrey B. Schwimmer, Manal F. Abdelmalek, Joel E. Lavine, and Anna Mae Diehl. “Hedgehog pathway and pediatric nonalcoholic fatty liver disease..” Hepatology (Baltimore, Md.) 57, no. 5 (May 2013): 1814–25. https://doi.org/10.1002/hep.26230.
       Full Text
    • Corbin, Karen D., Manal F. Abdelmalek, Melanie D. Spencer, Kerry-Ann da Costa, Joseph A. Galanko, Wei Sha, Ayako Suzuki, et al. “Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis..” Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology 27, no. 4 (April 2013): 1674–89. https://doi.org/10.1096/fj.12-219097.
       Full Text
    • Garrett, Melanie E., Manal F. Abdelmalek, Allison Ashley-Koch, Michael A. Hauser, Cynthia A. Moylan, Herbert Pang, Anna Mae Diehl, and Hans L. Tillmann. “IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients..” Journal of Hepatology 58, no. 2 (February 2013): 402–3. https://doi.org/10.1016/j.jhep.2012.09.035.
       Full Text
    • Garrett, M. E., M. F. Abdelmalek, A. Ashley-Koch, M. A. Hauser, C. A. Moylan, H. Pang, A. M. Diehl, and H. L. Tillmann. “IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients.” Journal of Hepatology 58, no. 2 (2013): 402–3. https://doi.org/10.1016/j.jhep.2012.09.035.
       Full Text
    • Swiderska-Syn, M., A. Suzuki, C. D. Guy, J. B. Schwimmer, M. F. Abdelmalek, J. E. Lavine, and A. M. Diehl. “Hedgehog pathway and pediatric nonalcoholic fatty liver disease.” Hepatology 57, no. 5 (2013): 1814–25. https://doi.org/10.1002/hep.26230.
       Full Text
    • Youssef, N. A., M. F. Abdelmalek, M. Binks, C. D. Guy, A. Omenetti, A. D. Smith, A. M. E. Diehl, and A. Suzuki. “Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease.” Liver International 33, no. 7 (2013): 1062–70. https://doi.org/10.1111/liv.12165.
       Full Text
    • Nelson, James E., Elizabeth M. Brunt, Kris V. Kowdley, and Kris V. Nonalcoholic Steatohepatitis Clinical Research Network. “Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations..” Hepatology (Baltimore, Md.) 56, no. 5 (November 2012): 1730–40. https://doi.org/10.1002/hep.25856.
       Full Text
    • Abdelmalek, Manal F., Mariana Lazo, Alena Horska, Susanne Bonekamp, Edward W. Lipkin, Ashok Balasubramanyam, John P. Bantle, et al. “Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes..” Hepatology (Baltimore, Md.) 56, no. 3 (September 2012): 952–60. https://doi.org/10.1002/hep.25741.
       Full Text
    • Syn, Wing-Kin, Kolade M. Agboola, Marzena Swiderska, Gregory A. Michelotti, Evaggelia Liaskou, Herbert Pang, Guanhua Xie, et al. “NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease..” Gut 61, no. 9 (September 2012): 1323–29. https://doi.org/10.1136/gutjnl-2011-301857.
       Full Text  Link to Item
    • Suzuki, Ayako, Manal F. Abdelmalek, Jeffrey B. Schwimmer, Joel E. Lavine, Ann O. Scheimann, Aynur Unalp-Arida, Katherine P. Yates, et al. “Association between puberty and features of nonalcoholic fatty liver disease..” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 10, no. 7 (July 2012): 786–94. https://doi.org/10.1016/j.cgh.2012.01.020.
       Full Text
    • Guy, Cynthia D., Ayako Suzuki, James L. Burchette, Elizabeth M. Brunt, Manal F. Abdelmalek, Diana Cardona, Shannon J. McCall, et al. “Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease..” Hum Pathol 43, no. 6 (June 2012): 790–800. https://doi.org/10.1016/j.humpath.2011.07.007.
       Full Text  Link to Item
    • Guy, Cynthia D., Ayako Suzuki, Marzena Zdanowicz, Manal F. Abdelmalek, James Burchette, Aynur Unalp, Anna Mae Diehl, and Anna Mae NASH CRN. “Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease..” Hepatology (Baltimore, Md.) 55, no. 6 (June 2012): 1711–21. https://doi.org/10.1002/hep.25559.
       Full Text
    • Corbin, Karen D., Melanie D. Spencer, Kerry-Ann da Costa, Wei Sha, Manal F. Abdelmalek, Yiping Pan, Ayako Suzuki, et al. “Genotype-based hierarchical clustering reveals a panel of polymorphisms in one carbon metabolism that are associated with obesity.” Faseb Journal 26 (April 1, 2012).
       Link to Item
    • Palmeri, M. L., M. F. Abdelmalek, and K. R. Nightingale. “Reply to: The use of acoustic radiation force-based shear stiffness in non-alcoholic fatty liver disease.” Journal of Hepatology 56, no. 4 (April 1, 2012). https://doi.org/10.1016/j.jhep.2011.09.007.
       Full Text
    • Abdelmalek, M. F., A. Humar, F. Stickel, P. Andreone, A. Pascher, E. Barroso, G. W. Neff, et al. “Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial..” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 12, no. 3 (March 2012): 694–705. https://doi.org/10.1111/j.1600-6143.2011.03919.x.
       Full Text
    • Ratziu, Vlad, Muhammad Y. Sheikh, Arun J. Sanyal, Joseph K. Lim, Hari Conjeevaram, Naga Chalasani, Manal Abdelmalek, et al. “A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis..” Hepatology (Baltimore, Md.) 55, no. 2 (February 2012): 419–28. https://doi.org/10.1002/hep.24747.
       Full Text
    • Syn, W. K., K. M. Agboola, M. Swiderska, G. A. Michelotti, E. Liaskou, H. Pang, G. Xie, et al. “NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.” Gut, 2012. https://doi.org/10.1136/gutjnl-2011-301857.
       Full Text
    • Vos, M. B., R. Colvin, P. Belt, J. P. Molleston, K. F. Murray, P. Rosenthal, J. Schwimmer, et al. “Correlation of Vitamin E, uric acid and diet composition with histologic features of pediatric nonalcoholic fatty liver disease.” Journal of Pediatric Gastroenterology and Nutrition 54, no. 1 (January 1, 2012): 90–96. https://doi.org/10.1097/MPG.0b013e318229da1a.
       Full Text
    • Palmeri, Mark L., Michael H. Wang, Ned C. Rouze, Manal F. Abdelmalek, Cynthia D. Guy, Barry Moser, Anna Mae Diehl, and Kathryn R. Nightingale. “Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease..” Journal of Hepatology 55, no. 3 (September 2011): 666–72. https://doi.org/10.1016/j.jhep.2010.12.019.
       Full Text
    • Rangwala, Fatima, Cynthia D. Guy, Jiuyi Lu, Ayako Suzuki, James L. Burchette, Manal F. Abdelmalek, Wei Chen, and Anna Mae Diehl. “Increased production of sonic hedgehog by ballooned hepatocytes..” J Pathol 224, no. 3 (July 2011): 401–10. https://doi.org/10.1002/path.2888.
       Full Text  Link to Item
    • Speliotes, Elizabeth K., Laura M. Yerges-Armstrong, Jun Wu, Ruben Hernaez, Lauren J. Kim, Cameron D. Palmer, Vilmundur Gudnason, et al. “Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits..” Plos Genetics 7, no. 3 (March 10, 2011). https://doi.org/10.1371/journal.pgen.1001324.
       Full Text
    • Syn, Wing-Kin, Steve S. Choi, Evaggelia Liaskou, Gamze F. Karaca, Kolade M. Agboola, Ye Htun Oo, Zhiyong Mi, et al. “Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis..” Hepatology 53, no. 1 (January 2011): 106–15. https://doi.org/10.1002/hep.23998.
       Full Text  Link to Item
    • Suzuki, Ayako, Manal F. Abdelmalek, Aynur Unalp-Arida, Katherine Yates, Arun Sanyal, Cynthia Guy, and Anna Mae Diehl. “Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease..” Clin Gastroenterol Hepatol 8, no. 12 (December 2010): 1062–69. https://doi.org/10.1016/j.cgh.2010.08.005.
       Full Text  Link to Item
    • Abdelmalek, Manal F., Ayako Suzuki, Cynthia Guy, Aynur Unalp-Arida, Ryan Colvin, Richard J. Johnson, Anna Mae Diehl, and Anna Mae Nonalcoholic Steatohepatitis Clinical Research Network. “Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease..” Hepatology 51, no. 6 (June 2010): 1961–71. https://doi.org/10.1002/hep.23535.
       Full Text  Link to Item
    • Levene, Adam P., Hiromi Kudo, Mark R. Thursz, Quentin M. Anstee, and Robert D. Goldin. “Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver?.” Hepatology (Baltimore, Md.) 51, no. 5 (May 2010). https://doi.org/10.1002/hep.23551.
       Full Text
    • Sánchez-Lozada, Laura G., Wei Mu, Carlos Roncal, Yuri Y. Sautin, Manal Abdelmalek, Sirirat Reungjui, MyPhuong Le, et al. “Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver..” European Journal of Nutrition 49, no. 1 (February 2010): 1–9. https://doi.org/10.1007/s00394-009-0042-x.
       Full Text
    • Lavine, Joel E., Jeffrey B. Schwimmer, Jean P. Molleston, Ann O. Scheimann, Karen F. Murray, Stephanie H. Abrams, Philip Rosenthal, et al. “Treatment of nonalcoholic fatty liver disease in children: TONIC trial design..” Contemporary Clinical Trials 31, no. 1 (January 2010): 62–70. https://doi.org/10.1016/j.cct.2009.09.001.
       Full Text
    • Abdelmalek, Manal F., Schuyler O. Sanderson, Paul Angulo, Consuelo Soldevila-Pico, Chen Liu, Joy Peter, Jill Keach, et al. “Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial..” Hepatology (Baltimore, Md.) 50, no. 6 (December 2009): 1818–26. https://doi.org/10.1002/hep.23239.
       Full Text
    • Shah, Amy G., Alison Lydecker, Karen Murray, Brent N. Tetri, Melissa J. Contos, Arun J. Sanyal, and Arun J. Nash Clinical Research Network. “Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease..” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 7, no. 10 (October 2009): 1104–12. https://doi.org/10.1016/j.cgh.2009.05.033.
       Full Text
    • Syn, Wing-Kin, Youngmi Jung, Alessia Omenetti, Manal Abdelmalek, Cynthia D. Guy, Liu Yang, Jiangbo Wang, et al. “Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease..” Gastroenterology 137, no. 4 (October 2009): 1478-1488.e8. https://doi.org/10.1053/j.gastro.2009.06.051.
       Full Text
    • Brunt, Elizabeth M., David E. Kleiner, Laura A. Wilson, Aynur Unalp, Cynthia E. Behling, Joel E. Lavine, Brent A. Neuschwander-Tetri, and Brent A. NASH Clinical Research NetworkA list of members of the Nonalcoholic Steatohepatitis Clinical Research Network can be found in the Appendix. “Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network..” Hepatology (Baltimore, Md.) 49, no. 3 (March 2009): 809–20. https://doi.org/10.1002/hep.22724.
       Full Text
    • Suzuki, Ayako, and Manal F. Abdelmalek. “Nonalcoholic fatty liver disease in women..” Women’S Health (London, England) 5, no. 2 (March 2009): 191–203. https://doi.org/10.2217/17455057.5.2.191.
       Full Text
    • Ouyang, Xiaosen, Pietro Cirillo, Yuri Sautin, Shannon McCall, James L. Bruchette, Anna Mae Diehl, Richard J. Johnson, and Manal F. Abdelmalek. “Fructose consumption as a risk factor for non-alcoholic fatty liver disease..” J Hepatol 48, no. 6 (June 2008): 993–99. https://doi.org/10.1016/j.jhep.2008.02.011.
       Full Text  Link to Item
    • Palmeri, M. L., M. H. Wang, K. D. Frinkley, K. R. Nightingale, M. F. Abdelmalek, and A. M. Diehl. “Dependence of in vivo, radiation force derived hepatic shear modulus estimates on imaging approach: Intercostal vs. subcostal.” Proceedings  Ieee Ultrasonics Symposium, December 1, 2007, 566–69. https://doi.org/10.1109/ULTSYM.2007.147.
       Full Text
    • Abdelmalek, Manal F., and Anna Mae Diehl. “Nonalcoholic fatty liver disease as a complication of insulin resistance..” Med Clin North Am 91, no. 6 (November 2007): 1125–ix. https://doi.org/10.1016/j.mcna.2007.06.001.
       Full Text  Link to Item
    • Purohit, Vishnudutt, Manal F. Abdelmalek, Shirish Barve, Norlin J. Benevenga, Charles H. Halsted, Neil Kaplowitz, Kusum K. Kharbanda, et al. “Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium..” Am J Clin Nutr 86, no. 1 (July 2007): 14–24. https://doi.org/10.1093/ajcn/86.1.14.
       Full Text  Link to Item
    • Abdelmalek, Manal F., Chen Liu, and John F. Valentine. “Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease..” The American Journal of Gastroenterology 102, no. 6 (June 2007): 1333–34. https://doi.org/10.1111/j.1572-0241.2007.01131.x.
       Full Text
    • Abdelmalek, Manal F., and Anna Mae Diehl. “De novo nonalcoholic fatty liver disease after liver transplantation..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 13, no. 6 (June 2007): 788–90. https://doi.org/10.1002/lt.21103.
       Full Text
    • Abdelmalek, Manal F., Lane B. Hellner, Marc Zumberg, Victor W. Melgen, and Richard Lottenberg. “Acute liver failure occurring immediately following anti-D immune globulin infusion in a patient with chronic hepatitis B infection..” Digestive Diseases and Sciences 52, no. 4 (April 2007): 914–19. https://doi.org/10.1007/s10620-006-9319-6.
       Full Text
    • Galhenage, Sumedha, Keyur Patel, Heathet M. Patton, Terry Walker, William Symonds, Manal F. Abdelmalek, and John G. Mchutchison. “The association of adipokine levels with changes in steatosis following treatment in patients with chronic hepatitis C infection.” Gastroenterology 132, no. 4 (April 1, 2007): A783–A783.
       Link to Item
    • Galhenage, S., and M. F. Abdelmalek. “The impact of steatosis and alcohol on hepatitis C.” Current Hepatitis Reports 6, no. 2 (January 1, 2007): 39–45. https://doi.org/10.1007/s11901-007-0002-y.
       Full Text
    • Abdelmalek, M. F., and A. M. Diehl. “Mechanisms underlying nonalcoholic steatohepatitis.” Drug Discovery Today: Disease Mechanisms 3, no. 4 (December 1, 2006): 479–88. https://doi.org/10.1016/j.ddmec.2006.11.001.
       Full Text
    • Abdelmalek, Manal F., Chen Liu, Jonathan Shuster, David R. Nelson, and Nabih R. Asal. “Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease..” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 4, no. 9 (September 2006): 1162–69. https://doi.org/10.1016/j.cgh.2006.06.001.
       Full Text
    • Samara, Karim, Chen Liu, Consuelo Soldevila-Pico, David R. Nelson, and Manal F. Abdelmalek. “Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantation..” Digestive Diseases and Sciences 51, no. 7 (July 2006): 1226–29. https://doi.org/10.1007/s10620-006-8038-3.
       Full Text
    • Machicao, Victor I., Titte R. Srinivas, Alan W. Hemming, Consuelo Soldevila-Pico, Roberto J. Firpi, Alan I. Reed, Giuseppi J. Morelli, David R. Nelson, and Manal F. Abdelmalek. “Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 12, no. 5 (May 2006): 754–61. https://doi.org/10.1002/lt.20686.
       Full Text
    • Morelli, Giuseppe, Alan Reed, Roberto J. Firpi, Victor Machicao, Manal F. Abdelmalek, Consuelo Soldevilla-Pico, and David R. Nelson. “Late presentation of a biliary tract complication after right hepatic donation resulting in secondary biliary cirrhosis..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 12, no. 2 (February 2006): 306–9. https://doi.org/10.1002/lt.20687.
       Full Text
    • Firpi, Roberto J., Haizhen Zhu, Giuseppe Morelli, Manal F. Abdelmalek, Consuelo Soldevila-Pico, Victor I. Machicao, Roniel Cabrera, Alan I. Reed, Chen Liu, and David R. Nelson. “Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 12, no. 1 (January 2006): 51–57. https://doi.org/10.1002/lt.20532.
       Full Text
    • Firpi, Roberto J., Consuelo Soldevila-Pico, Manal F. Abdelmalek, Giuseppe Morelli, Joel Judah, and David R. Nelson. “Short recovery time after percutaneous liver biopsy: should we change our current practices?.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 3, no. 9 (September 2005): 926–29. https://doi.org/10.1016/s1542-3565(05)00294-6.
       Full Text
    • Lucey, Michael R., Manal F. Abdelmalek, Rosemarie Gagliardi, Darla Granger, Curtis Holt, Igal Kam, Goran Klintmalm, et al. “A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status..” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 5, no. 5 (May 2005): 1111–19. https://doi.org/10.1111/j.1600-6143.2005.00808.x.
       Full Text
    • Reed, A., R. J. Howard, S. Fujita, D. P. Foley, M. R. Langham, J. D. Schold, D. Nelson, et al. “Liver retransplantation: a single-center outcome and financial analysis..” Transplantation Proceedings 37, no. 2 (March 2005): 1161–63. https://doi.org/10.1016/j.transproceed.2004.11.046.
       Full Text
    • Firpi, Roberto J., Manal F. Abdelmalek, Consuelo Soldevila-Pico, Roniel Cabrera, Jonathan J. Shuster, Douglas Theriaque, Alan I. Reed, et al. “One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 10, no. 10 (October 2004): 1240–47. https://doi.org/10.1002/lt.20238.
       Full Text
    • Abdelmalek, Manal F., Roberto J. Firpi, Consuelo Soldevila-Pico, Alan I. Reed, Alan W. Hemming, Chen Liu, James M. Crawford, Gary L. Davis, and David R. Nelson. “Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 10, no. 2 (February 2004): 199–207. https://doi.org/10.1002/lt.20074.
       Full Text
    • Abdelmalek, Manal F., Tousif M. Pasha, Nizar N. Zein, David H. Persing, Russell H. Wiesner, and David D. Douglas. “Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 9, no. 12 (December 2003): 1253–57. https://doi.org/10.1016/j.lts.2003.09.013.
       Full Text
    • Nelson, David R., Zhengkun Tu, Consuelo Soldevila-Pico, Manal Abdelmalek, Haizhen Zhu, Yi Ling Xu, Roniel Cabrera, Chen Liu, and Gary L. Davis. “Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect..” Hepatology (Baltimore, Md.) 38, no. 4 (October 2003): 859–68. https://doi.org/10.1053/jhep.2003.50427.
       Full Text
    • Rosenberg, Eric I., Girish Mishra, and Manal F. Abdelmalek. “Angiotensin-converting enzyme inhibitor-induced isolated visceral angioedema in a liver transplant recipient..” Transplantation 75, no. 5 (March 2003): 730–32. https://doi.org/10.1097/01.tp.0000048491.67462.da.
       Full Text
    • Firpi, Roberto J., Manal F. Abdelmalek, Consuelo Soldevila-Pico, Alan Reed, Alan Hemming, Richard Howard, William Van Der Werf, et al. “Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 8, no. 11 (November 2002): 1000–1006. https://doi.org/10.1053/jlts.2002.34968.
       Full Text
    • Nelson, D. R., C. Soldevila-Pico, A. Reed, M. F. Abdelmalek, A. W. Hemming, W. J. Van der Werf, R. Howard, and G. L. Davis. “Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation..” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 7, no. 12 (December 2001): 1064–70. https://doi.org/10.1053/jlts.2001.29414.
       Full Text
    • Abdelmalek, M. F., P. Angulo, R. A. Jorgensen, P. B. Sylvestre, and K. D. Lindor. “Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study.” American Journal of Gastroenterology 96, no. 9 SUPPL. (October 3, 2001): 2711–17. https://doi.org/10.1016/S0002-9270(01)02691-0.
       Full Text
    • Abdelmalek, M. F., P. Angulo, R. A. Jorgensen, P. B. Sylvestre, and K. D. Lindor. “Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study..” The American Journal of Gastroenterology 96, no. 9 (September 2001): 2711–17. https://doi.org/10.1111/j.1572-0241.2001.04129.x.
       Full Text
    • Maiwald, M., A. von Herbay, D. H. Persing, P. P. Mitchell, M. F. Abdelmalek, J. N. Thorvilson, D. N. Fredricks, and D. A. Relman. “Tropheryma whippelii DNA is rare in the intestinal mucosa of patients without other evidence of Whipple disease..” Annals of Internal Medicine 134, no. 2 (January 2001): 115–19. https://doi.org/10.7326/0003-4819-134-2-200101160-00011.
       Full Text
    • O’Duffy, J. D., W. L. Griffing, C. Y. Li, M. F. Abdelmalek, and D. H. Persing. “Whipple's arthritis: direct detection of Tropheryma whippelii in synovial fluid and tissue..” Arthritis and Rheumatism 42, no. 4 (April 1999): 812–17. https://doi.org/10.1002/1529-0131(199904)42:4<812::aid-anr27>3.0.co;2-s.
       Full Text
    • Abdelmalek, M. F., M. E. Harrison, J. B. Gross, J. J. Poterucha, A. A. Gossard, J. R. Spivey, J. Rakela, and K. D. Lindor. “Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial..” Journal of Clinical Gastroenterology 26, no. 2 (March 1998): 130–34. https://doi.org/10.1097/00004836-199803000-00009.
       Full Text
    • Abdelmalek, M. F., B. A. Pockaj, and J. A. Leighton. “Rectal bleeding from a mucous fistula secondary to a Dieulafoy's lesion..” Journal of Clinical Gastroenterology 24, no. 4 (June 1997): 259–61. https://doi.org/10.1097/00004836-199706000-00017.
       Full Text
    • Abdelmalek, M. F., and D. D. Douglas. “Lisinopril-induced isolated visceral angioedema: review of ACE-inhibitor-induced small bowel angioedema..” Digestive Diseases and Sciences 42, no. 4 (April 1997): 847–50. https://doi.org/10.1023/a:1018884702345.
       Full Text
    • Abdelmalek, M. F., and D. D. Douglas. “Alendronate-induced ulcerative esophagitis..” The American Journal of Gastroenterology 91, no. 6 (June 1996): 1282–83.
    • Abdelmalek, M. F., and P. C. Spittell. “79-year-old woman with blue toes..” Mayo Clinic Proceedings 70, no. 3 (March 1995): 292–95. https://doi.org/10.1016/s0025-6196(11)64950-1.
       Full Text
    • Abdelmalek, M., J. Ludwig, and K. D. Lindor. “Two cases from the spectrum of nonalcoholic steatohepatitis..” Journal of Clinical Gastroenterology 20, no. 2 (March 1995): 127–30.

  • Conference Papers

    • Paredes, Angelo H., James F. Trotter, Mustafa R. Bashir, Guy W. Neff, Manal F. Abdelmalek, Grisell Ortiz-Lasanta, Mark Jaros, et al. “NGM282 Maintains a Durable Off-Treatment Response on Hepatic Steatosis, Inflammation and Fibrogenesis in Patients with Biopsy-Confirmed Nonalcoholic Steatohepatitis: Results of a Multi-Center Phase 2 Dose-Finding Study.” In Hepatology, 68:1460A-1461A. WILEY, 2018.
       Link to Item
    • Abdelmalek, Manal F., Bradley L. Freilich, Stephen A. Harrison, Elizabeth E. Powell, Mary E McCarthy Rinella, Neta Tobis, Dan Peres, Jerry Kanellos, Gadi Lalazar, and Arun J. Sanyal. “Imm-124E Improves Metabolic Endotoxemia and Markers of Liver Injury in Nonalcoholic Steatohepatitis.” In Hepatology, 68:68A-69A. WILEY, 2018.
       Link to Item
    • Abdelmalek, Manal F., Nicolas Lanthier, Mario Chojkier, Johannes Kluwe, Andrew J. Fowell, Jiacheng Yuan, Jean Paul Nicandro, et al. “Cenicriviroc Treatment over 2 Years Results in Clinically Meaningful and Sustained Improvement in Fibrosis in Adults with Nonalcoholic Steatohepatitis and Severe Liver Fibrosis.” In Hepatology, 68:1287A-1287A. WILEY, 2018.
       Link to Item
    • Chalasani, Naga P., Eric J. Lawitz, Manal F. Abdelmalek, Mary E McCarthy Rinella, Stephen A. Harrison, Arun J. Sanyal, Mazen Noureddin, et al. “The Noninvasive Point of Care MBT Accurately Predicts Decompensation Events Better Than MELD in Compensated (MELD < 15) Nash Cirrhotics.” In Hepatology, 68:769A-770A. WILEY, 2018.
       Link to Item
    • Chaudhry, Mohammad, Cynthia A. Moylan, Michael S. Middleton, Alfredo Farjat, Kingshuk Roy Chaudhury, Cynthia D. Guy, Manal F. Abdelmalek, Rohit Loomba, Claude B. Sirlin, and Mustafa Bashir. “Quantifying the Placebo Effect on Liver Fat Using Magnetic Resonance Imaging-Proton Density Fat Fraction in NAFLD Clinical Trials.” In Hepatology, 68:68A-68A. WILEY, 2018.
       Link to Item
    • Halegoua-De Marzio, Dina, Paul J. Thuluvath, Manal F. Abdelmalek, Courtney Van Biene, Reshma Shringarpure, and Leigh MacConell. “Obeticholic Acid Was Safe and Well Tolerated in Patients with Nonalcoholic Steatohepatitis and Compensated Cirrhosis: A Secondary Analysis of the Control Study.” In Hepatology, 68:45A-45A. WILEY, 2018.
       Link to Item
    • Moylan, Cynthia A., Patricia A. Sorrow, Alisha Mavis, Mustafa Bashir, Dereje Jima, Rachel Maguire, Erol Bozdogan, et al. “Obesity and Nonalcoholic Fatty Liver Disease in Childhood Associate with Altered DNA Methylation in Early Life.” In Hepatology, 68:949A-950A. WILEY, 2018.
       Link to Item
    • Neuschwander-Tetri, Brent A., Kris V. Kowdley, Arun J. Sanyal, Manal F. Abdelmalek, Norah Terrault, Arthur J. McCullough, Peter Wang, et al. “Efficacy and Safety of Obeticholic Acid in Patients with Non-Alcoholic Steatohepatitis and Significant Fibrosis Using Endpoint Definitions and Populations Accepted for Registrational Studies.” In Hepatology, 68:952A-952A. WILEY, 2018.
       Link to Item
    • Bae, Andrew, Ricardo Henao, Ayako Suzuki, Cynthia A. Moylan, Cynthia D. Guy, Anna Mae Diehl, and Manal F. Abdelmalek. “STATIN USE AND LIVER INJURY IN NONALCOHOLIC FATTY LIVER DISEASE: RESULTS OF A PAIRED CLINICAL AND GENE EXPRESSION PROFILE ANALYSIS.” In Gastroenterology, 154:S1085–86. W B SAUNDERS CO-ELSEVIER INC, 2018.
       Link to Item
    • DEPAOLI, A. L. E. X., S. T. E. P. H. E. N. J. ROSSI, L. E. I. LING, S. T. E. P. H. E. N. A. HARRISON, M. A. N. A. L. F. ABDELMALEK, M. A. R. K. R. JAROS, and R. A. N. S. I. SOMARATNE. “NGM282 Significantly Reduces Hepatic Steatosis Independent of Type 2 Diabetes (T2D) Status or Statin Usage—Results from a Phase 2 Trial in Patients with Nonalcoholic Steatohepatitis (NASH).” In Diabetes, 67:1-LB. American Diabetes Association, 2018. https://doi.org/10.2337/db18-1-lb.
       Full Text
    • Du, Kuo, Richard Premont, Jeongeun Hyun, Mariana V. Machado, Cynthia A. Moylan, Manal F. Abdelmalek, Cynthia D. Guy, and Anna Mae Diehl. “PATHPHYSIOLOGICAL ROLE OF GLUTAMINOLYSIS IN HUMAN NAFLD PROGRESSION.” In Gastroenterology, 154:S950–51. W B SAUNDERS CO-ELSEVIER INC, 2018.
       Link to Item
    • Lefebvre, Eric, Vlad Ratziu, Arun J. Sanyal, Sven M. Francque, Vincent Wong, Rohit Loomba, Zachary Goodman, et al. “CENICRIVIROC TREATMENT FOR ADULTS WITH NON-ALCOHOLIC STEATOHEPATITIS: YEAR 2 ANALYSIS OF THE PHASE 2B CENTAUR STUDY.” In Gastroenterology, 154:S1085–S1085. W B SAUNDERS CO-ELSEVIER INC, 2018.
       Link to Item
    • Ridder, Gustaaf de, Ayako Suzuki, Liyan Xu, Diana Cardona, Jeff Groth, Rupa Ray, Manal F. Abdelmalek, Salvatore V. Pizzo, and Cynthia Guy. “GRP78 Immunohistochemistry Outperforms HSP70 for the Diagnosis of Cirrhotic- and Noncirrhotic-HCC.” In Modern Pathology, 31:632–632. NATURE PUBLISHING GROUP, 2018.
       Link to Item
    • Ridder, Gustaaf de, Ayako Suzuki, Liyan Xu, Diana Cardona, Jeff Groth, Rupa Ray, Manal F. Abdelmalek, Salvatore V. Pizzo, and Cynthia Guy. “GRP78 Immunohistochemistry Outperforms HSP70 for the Diagnosis of Cirrhotic- and Noncirrhotic-HCC.” In Laboratory Investigation, 98:632–632. NATURE PUBLISHING GROUP, 2018.
       Link to Item
    • Schild, Michael, Liyan Xu, Ayako Suzuki, Diana Cardona, Lani Clinton, Shannon McCall, Avani Pendse, et al. “Sonic Hedgehog Immunohistochemistry Improves Inter-observer Agreement for Ballooning and the Diagnosis of Nonalcoholic Steatohepatitis (NASH) among Less Experienced Liver Pathologists.” In Modern Pathology, 31:648–49. NATURE PUBLISHING GROUP, 2018.
       Link to Item
    • Schild, Michael, Liyan Xu, Ayako Suzuki, Diana Cardona, Lani Clinton, Shannon McCall, Avani Pendse, et al. “Sonic Hedgehog Immunohistochemistry Improves Inter-observer Agreement for Ballooning and the Diagnosis of Nonalcoholic Steatohepatitis (NASH) among Less Experienced Liver Pathologists.” In Laboratory Investigation, 98:648–49. NATURE PUBLISHING GROUP, 2018.
       Link to Item
    • Abdelmalek, Manal F., Anna Mae Diehl, Cynthia D. Guy, Dana Portenier, Ranjan Sudan, Xiaojun Li, Larry Mimms, and Anjali Jain. “Serum-Based Biomarker Accurately Stratifies Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis.” In Hepatology, 66:55A-56A. WILEY, 2017.
       Link to Item
    • Abdelmalek, Manal F., Edgar D. Charles, Brent A. Neuschwander-Tetri, Dina Halegoua-DeMarzio, Arun J. Sanyal, Robert W. Herring, Eric Lawitz, et al. “Baseline Serum Pro-C3 Predicts Response to BMS-986036 (peg-FGF21): A Secondary Analysis of a Multi-Center Clinical Trial in Non-Alcoholic Steatohepatitis (NASH).” In Hepatology, 66:1114A-1115A. WILEY, 2017.
       Link to Item
    • Abdelmalek, Manal F., Melanie Thompson, Joseph C. Gathe, Eric Lefebvre, Star Seyedkazemi, Netanya Sandler Utay, and Sven Francque. “Favorable safety and tolerability of the dual CCR2/5 antagonist cenicriviroc in over 1000 subjects treated to date.” In Hepatology, 66:1177A-1177A. WILEY, 2017.
       Link to Item
    • Abdelmalek, Manal F., Ricardo Henao, Ying Wang, Cynthia D. Guy, Mustafa R. Bashir, Richard Johnson, Anna Mae Diehl, and Brian Soher. “Fructose-Related Hepatic ATP Depletion Induces Hyperuricemia in Healthy Volunteers and Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease..” In Hepatology, 66:1104A-1105A. WILEY, 2017.
       Link to Item
    • Bosch, Jaime, Manal F. Abdelmalek, Mitchell L. Shiffman, Anna Mae Diehl, Stephen H. Caldwell, Don C. Rockey, Reem Ghalib, et al. “Variability in measurement of hepatic venous pressure gradient (HVPG) in patients with compensated cirrhosis due to NASH: Results from a randomized, controlled trial.” In Hepatology, 66:252A-252A. WILEY, 2017.
       Link to Item
    • Bosch, Jaime, Stephen A. Harrison, Manal F. Abdelmalek, Mitchell L. Shiffman, Anna Mae Diehl, Stephen H. Caldwell, Don C. Rockey, et al. “Hepatic venous pressure gradient (HVPG) predicts clinical disease progression in patients with compensated cirrhosis due to NASH.” In Hepatology, 66:244A-245A. WILEY, 2017.
       Link to Item
    • Goodman, Zachary D., Lakshmi Alaparthi, Fanny Monge, Keyur Patel, Rohit Loomba, Stephen H. Caldwell, Eric Lawitz, et al. “Prospective validation of hepatic collagen content for the prediction of clinical disease progression.” In Hepatology, 66:1111A-1112A. WILEY, 2017.
       Link to Item
    • Guy, Cynthia D., Ayako Suzuki, Marzena Swiderska-Syn, Manal F. Abdelmalek, and Anna Mae Diehl. “Hepatocellular injury and senescence in NASH are linked to Hedgehog and Hippo pathway activity and accumulation of hepatic progenitor cells.” In Hepatology, 66:1153A-1154A. WILEY, 2017.
       Link to Item
    • Harrison, Stephen A., Manal F. Abdelmalek, Anna Mae Diehl, Stephen Caldwell, Mitchell L. Shiffman, Reem Ghalib, Eric Lawitz, et al. “Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis.” In Hepatology, 66:1120A-1121A. WILEY, 2017.
       Link to Item
    • Li, Xiaoyi, Cynthia A. Moylan, Susan S. Baker, Wensheng Liu, Robert D. Baker, Susan K. Murphy, Manal F. Abdelmalek, Ruixin Zhu, Anna Mae Diehl, and Lixin Zhu. “Altered liver methylome and transcriptome provide evidence for epigenetic contribution to NAFLD pathogenesis.” In Hepatology, 66:1071A-1072A. WILEY, 2017.
       Link to Item
    • Loomba, Rohit, Eric Lawitz, Reem Ghalib, Magdy Elkhashab, Stephen H. Caldwell, Manal F. Abdelmalek, Kris V. Kowdley, et al. “Reductions in liver stiffness by magnetic resonance elastography (MRE) predict fibrosis improvement in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH).” In Hepatology, 66:1109A-1110A. WILEY, 2017.
       Link to Item
    • Loomba, Rohit, Manal F. Abdelmalek, James F. Trotter, Angelo H. Paredes, Mark Jaros, Lei Ling, Stephen J. Rossi, Alex M. DePaoli, Mary E. Rinella, and Stephen A. Harrison. “NGM282 Significantly Reduces Hepatic Steatosis Independent of Baseline Patient Characteristics and Highly Correlates with Markers of FGFR4 Target Engagement: Results from a Phase 2 Trial in Biopsy-Confirmed NASH Patients.” In Hepatology, 66:1152A-1152A. WILEY, 2017.
       Link to Item
    • Moylan, Cynthia A., Alisha M. Mavis, Mustafa R. Bashir, David Malik, Erol Bozdogan, Stephanie Buie, Cathrine Hoyo, Anna Mae Diehl, Susan K. Murphy, and Manal F. Abdelmalek. “Visceral and subcutaneous adipose tissue measurements associate with increased metabolic risk for NAFLD in pre-pubertal obese children.” In Hepatology, 66:665A-665A. WILEY, 2017.
       Link to Item
    • Rinella, Mary E., James F. Trotter, Guy Neff, Grisell Ortiz-Lasanta, Manal F. Abdelmalek, Marcelo Kugelmas, Angelo H. Paredes, et al. “NGM282 Induces Low Density Lipoprotein Cholesterol (LDLc) Changes, Consistent with Potent FGFR4 Signaling, which are Rapidly Mitigated with Statin Therapy in Patients with Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH).” In Hepatology, 66:1132A-1133A. WILEY, 2017.
       Link to Item
    • Sanyal, Arun J., Edgar D. Charles, Brent A. Neuschwander-Tetri, Rohit Loomba, Stephen A. Harrison, Manal F. Abdelmalek, Eric Lawitz, et al. “BMS-986036 (pegylated FGF21) in patients with non-alcoholic steatohepatitis: A phase 2 study.” In Hepatology, 66:104A-105A. WILEY, 2017.
       Link to Item
    • Vuppalanchi, Raj, Eric Lawitz, Manal F. Abdelmalek, Mary E. Rinella, Stephen A. Harrison, Michael J. Ryan, Peter G. Traber, Guadalupe Garcia-Tsao, and Naga P. Chalasani. “Liver Stiffness Measured By Vibration Controlled Transient Elastography Is An Excellent Surrogate for Identifying Clinically Significant Portal Hypertension In Patients With Compensated NASH Cirrhosis.” In Hepatology, 66:245A-245A. WILEY, 2017.
       Link to Item
    • Wegermann, Kara, Cynthia A. Moylan, Jiayin Zheng, Manal F. Abdelmalek, Shein-Chung Chow, Cynthia D. Guy, Anna Mae Diehl, and Ayako Suzuki. “Gender and menopause significantly modify effects of metabolism-related SNPs on fibrosis stage in adult patients with nonalcoholic fatty liver disease (NAFLD).” In Hepatology, 66:55A-55A. WILEY, 2017.
       Link to Item
    • Younossi, Zobair M., Maria Stepanova, Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Bryan J. McColgan, Robert P. Myers, et al. “Predictors of Fibrosis Progression and Regression by Histology and Morphometrically Quantified Collagen in Patients with Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis.” In Hepatology, 66:1171A-1171A. WILEY, 2017.
       Link to Item
    • Younossi, Zobair M., Maria Stepanova, Stephen A. Harrison, Arun J. Sanyal, Vlad Ratziu, Bryan J. McColgan, Robert P. Myers, et al. “Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis.” In Hepatology, 66:1154A-1155A. WILEY, 2017.
       Link to Item
    • Moylan, Cynthia A., Ricardo Henao Giraldo, Susan K. Murphy, Anna Mae Diehl, and Manal F. Abdelmalek. “Differential DNA Methylation in Whole Blood Reflects that in Liver and Distinguishes Patients with Advanced NAFLD Fibrosis from Those with Normal Histology: A Potential Non-Invasive Tool.” In Gastroenterology, 152:S1069–70. Elsevier BV, 2017. https://doi.org/10.1016/s0016-5085(17)33611-9.
       Full Text
    • Sanyal, Arun, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Stephen H. Caldwell, Mitchell L. Shiffman, et al. “Changes in Fibrosis, but not the Nafld Activity Score (NAS), are Associated with Disease Progression in Patients with Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis.” In Gastroenterology, 152:S1055–S1055. Elsevier BV, 2017. https://doi.org/10.1016/s0016-5085(17)33563-1.
       Full Text
    • Sanyal, Arun J., Vlad Ratziu, Stephen Harrison, Manal F. Abdelmalek, Guruprasad P. Aithal, Juan Caballeria, Sven M. Francque, et al. “Cenicriviroc placebo for the treatment of non-alcoholic steatohepatitis with liver fibrosis: Results from the Year 1 primary analysis of the Phase 2b CENTAUR study Abstracts.” In Hepatology, 64:1118A-1119A. WILEY, 2016.
       Link to Item
    • Corey, Kathleen E., Katherine P. Yates, Manal F. Abdelmalek, Arun J. Sanyal, Brent A. Tetri, Kris V. Kowdley, Oscar Cummings, James Tonascia, and Naga P. Chalasani. “Longitudinal relationship between changes in liver histology and renal function in adults with NASH: The NASH Clinical Research Network Experience.” In Hepatology, 64:20A-20A. WILEY, 2016.
       Link to Item
    • Hameed, Bilal, Norah Terrault, Rohit Loomba, Arthur J. McCullough, Manal F. Abdelmalek, Kris V. Kowdley, Brent A. Tetri, et al. “Subgroup Analysis Comparing Obeticholic Acid versus Placebo for Fibrosis Improvement: a Post-hoc Analysis of the FLINT Trial.” In Hepatology, 64:541A-542A. WILEY, 2016.
       Link to Item
    • Moylan, Cynthia A., Kara J. Wegermann, Ricardo G. Henao, Susan K. Murphy, Anna Mae Diehl, and Manal F. Abdelmalek. “BCAT1 Is Associated with Clinical Decompensation in Nonalcoholic Fatty Liver Disease: a Pilot Study.” In American Journal of Gastroenterology, 111:S381–S381. NATURE PUBLISHING GROUP, 2016.
       Link to Item
    • Patel, Yuval A., Ricardo Henao, Cynthia A. Moylan, Cynthia D. Guy, Dawn L. Piercy, Anna Mae Diehl, and Manal F. Abdelmalek. “Vitamin D is Not Associated with Histologic Severity in NAFLD: Results of a Paired Clinical and Hepatic Gene Expression Profile Analysis.” In Hepatology, 64:577A-577A. WILEY, 2016.
       Link to Item
    • Suzuki, Ayako, Horace J. Spencer, Cynthia A. Moylan, Jonathan A. Dranoff, Manal F. Abdelmalek, Cynthia D. Guy, and Anna Mae Diehl. “Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD).” In Hepatology, 64:105A-105A. WILEY, 2016.
       Link to Item
    • Vuppalanchi, Raj, Manal F. Abdelmalek, Eric Lawitz, Peter G. Traber, Adam E. Allgood, Stephen A. Harrison, Zachary D. Goodman, Naga P. Chalasani, and Guadalupe Garcia-Tsao. “Vibration-Controlled Transient Elastography (VCTE) is Useful in Identifying Clinically Significant Portal Hypertension in Patients with NASH Cirrhosis.” In Hepatology, 64:844A-845A. WILEY, 2016.
       Link to Item
    • Wegermann, Kara, Ricardo Henao, Yiping Pan, Anna Mae Diehl, Manal F. Abdelmalek, and Cynthia A. Moylan. “BCAT1 is Associated with Clinical Decompensation in NAFLD: A Pilot Study.” In Hepatology, 64:577A-577A. WILEY, 2016.
       Link to Item
    • Kowdley, Kris V., Manal F. Abdelmalek, Arthur McCullough, Rohit Loomba, Bilal Hameed, Naga P. Chalasani, Brent Neuschwander-Tetri, et al. “Mo1557 Evaluation of Effects of Concomitant Medications for NASH and Associated Comorbidities on Histological Improvements With Obeticholic Acid.” In Gastroenterology, 150:S1144–S1144. Elsevier BV, 2016. https://doi.org/10.1016/s0016-5085(16)33861-6.
       Full Text
    • Abdelmalek, Manal F., Kris V. Kowdley, Norah Terrault, Brent A. Neuschwander-Tetri, Arun J. Sanyal, Rohit Loomba, Xiaohong Yan, Reshma Shringarpure, David Shapiro, and Arthur J. McCullough. “Effect of biopsy length on histological response assessment in NASH trials: A secondary analysis of FLINT Trial.” In Hepatology, 62:1256A-1257A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Bosch, Jaime, Vlad Ratziu, Don C. Rockey, Reem H. Ghalib, Paul J. Thuluvath, Ingolf Schiefke, Steven L. Flamm, et al. “Correlation between noninvasive markers of fibrosis and the hepatic venous pressure gradient (HVPG) in patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH).” In Hepatology, 62:578A-578A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Chalasani, Naga P., Rohit Loomba, Norah Terrault, Arthur J. McCullough, Manal F. Abdelmalek, Kris V. Kowdley, Brent A. Neuschwander-Tetri, et al. “Longitudinal changes in FIB-4 and improvement in fibrosis stage with obeticholic acid: A secondary analysis of FLINT Trial.” In Hepatology, 62:332A-333A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Goodman, Zachary D., Lakshmi Alaparthi, Fanny Monge, Keyur Patel, Rohit Loomba, Stephen H. Caldwell, Eric Lawitz, et al. “Correlations between hepatic morphometric collagen content, histologic fibrosis staging, and serum markers in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH).” In Hepatology, 62:906A-906A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Harrison, Stephen A., Arun J. Sanyal, Sven M. Francque, Pierre Bedossa, Lawrence Serfaty, Manuel Romero-Gomez, Paul Cales, et al. “Beneficial effects of the dual PPAR alpha-delta agonist, GFT505, on hepatic and cardiometabolic markers in adult NASH patients..” In Hepatology, 62:291A-292A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Harrison, Stephen A., Zachary D. Goodman, Vlad Ratziu, Rohit Loomba, Anna Mae Diehl, Eric Lawitz, Holger Hinrichsen, et al. “Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH).” In Hepatology, 62:910A-910A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Hasanaliyeva, Nigar, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Robert Streilein, Russell Hall, Anna Mae Diehl, and Manal F. Abdelmalek. “IL-8 and MCP1 are Independently Associated with Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.” In Hepatology, 62:1265A-1265A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Henao, Ricardo, Nigar Hasanaliyeva, Lauren N. Bell, Jacob Wulff, Regis Perichon, Cynthia A. Moylan, James T. Lu, Cynthia D. Guy, Anna Mae Diehl, and Manal F. Abdelmalek. “Plasma Metabolomic Profiles Predict Advanced Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.” In Hepatology, 62:290A-291A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Loomba, Rohit, Arun J. Sanyal, Kris V. Kowdley, Norah Terrault, Naga P. Chalasani, Manal F. Abdelmalek, Arthur J. McCullough, et al. “Predictors of improvement in NAFLD Activity Score to obeticholic acid: A secondary analysis of FLINT Trial.” In Hepatology, 62:1257A-1257A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Moylan, Cynthia A., Susan K. Murphy, Carole Grenier, Manal F. Abdelmalek, and Anna Mae Diehl. “DNA Methylation Profiles of Fibrosis-Associated Gene in Blood Reflects Liver Fibrosis Severity in Human Nonalcoholic Fatty Liver Disease.” In Hepatology, 62:648A-649A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Ratziu, Vlad, Arun J. Sanyal, Rohit Loomba, Stephen H. Caldwell, Reem H. Ghalib, Dawn M. Torres, Arthur J. McCullough, et al. “Characterization of insulin resistance in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH).” In Hepatology, 62:1298A-1299A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Ratziu, Vlad, Stephen A. Harrison, Sven M. Francque, Pierre Bedossa, Lawrence Serfaty, Manuel Romero-Gomez, Paul Cales, et al. “An international, phase 2 randomized controlled trial of the dual PPAR alpha-delta agonist GFT505 in adult patients with NASH.” In Hepatology, 62:262A-263A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Sanyal, Arun J., Stephen A. Harrison, Sven M. Francque, Pierre Bedossa, Lawrence Serfaty, Manuel Romero-Gomez, Paul Cales, et al. “The hepatic and extra-hepatic profile of resolution of steatohepatitis induced by GFT-505.” In Hepatology, 62:1252A-1252A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Sanyal, Arun J., Zachary D. Goodman, Manal F. Abdelmalek, Stephen A. Harrison, Don C. Rockey, Anna Mae Diehl, Stephen H. Caldwell, et al. “Clinical and histologic correlates of the hepatic venous pressure gradient (HVPG) in patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH).” In Hepatology, 62:577A-577A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Vuppalanchi, Raj, Mohammad S. Siddiqui, Erin K. Hallinan, Manal F. Abdelmalek, Brent A. Neuschwander-Tetri, Rohit Loomba, Kris V. Kowdley, et al. “Transient Elastography is Feasible with High Success Rate for Evaluation of Non-Alcoholic Fatty Liver Disease (NAFLD) in a Multicenter Setting.” In Hepatology, 62:1290A-1290A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Zhu, Ruixin, Susan S. Baker, Cynthia A. Moylan, Manal F. Abdelmalek, Cynthia D. Guy, Fausto Zamboni, Dingfeng Wu, et al. “Systematic Analysis of NAFLD Transcriptome Revealed Elevated Expression of Alcohol Metabolizing Genes in Mild and Severe NAFLD Livers.” In Gastroenterology, 148:S1054–S1054. W B SAUNDERS CO-ELSEVIER INC, 2015.
       Link to Item
    • Kochhar, Sweta, Manal F. Abdelmalek, Cynthia D. Guy, Dawn Piercy, Yiping Pan, Anna Mae Diehl, and Ayako Suzuki. “Associations of Sleep Duration and Sleep Quality With Clinical and Histologic Features of Nonalcoholic Fatty Liver Disease (NAFLD).” In Gastroenterology, 146:S931–S931. W B SAUNDERS CO-ELSEVIER INC, 2014.
       Link to Item
    • Yang, Ju Dong, Manal F. Abdelmalek, Cynthia D. Guy, Ryan M. Gill, Katherine P. Yates, Aynur Unalp, Joel E. Lavine, Anna Mae Diehl, and Ayako Suzuki. “Associations of Sex and Menopause With Histologic Severity of Necroinflammation and Portal Inflammation Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD).” In Gastroenterology, 146:S945–S945. W B SAUNDERS CO-ELSEVIER INC, 2014.
       Link to Item
    • Yang, Ju Dong, Manal F. Abdelmalek, Herbert Pang, Cynthia D. Guy, Alastair D. Smith, Anna Mae Diehl, and Ayako Suzuki. “Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis..” In Hepatology (Baltimore, Md.), 59:1406–14, 2014. https://doi.org/10.1002/hep.26761.
       Full Text
    • Bohinc, Brittany, Gregory A. Michelotti, Guanhua Xie, Herbert Pang, Ayako Suzuki, Cynthia D. Guy, Dawn L. Piercy, et al. “Repair-related Activation of Hedgehog Signaling in Stromal Cells Promotes Intrahepatic Hypothyroidism.” In Hepatology, 60:411A-412A. WILEY-BLACKWELL, 2014.
       Link to Item
    • Deng, Y., M. L. Palmeri, N. C. Rouze, S. J. Rosenzweig, M. F. Abdelmalek, and K. R. Nightingale. “Analyzing the impact of increasing Mechanical Index (MI) and energy deposition on shear wave speed (SWS) reconstruction in human liver.” In Ieee International Ultrasonics Symposium, Ius, 719–22, 2014. https://doi.org/10.1109/ULTSYM.2014.0177.
       Full Text
    • Klair, Jagpal S., Ju Dong Yang, Manal F. Abdelmalek, Cynthia D. Guy, Ryan M. Gill, Katherine P. Yates, Aynur Unalp-Arida, et al. “Risk of severe fibrosis is associated with age at menopause in nonalcoholic fatty liver disease (NAFLD).” In Hepatology, 60:621A-621A. WILEY-BLACKWELL, 2014.
       Link to Item
    • Urban, Thomas J., Cynthia A. Moylan, Matthew Rein, Manal F. Abdelmalek, David B. Goldstein, and Anna Mae Diehl. “Whole Exome Sequencing of Extreme Phenotypes of NAFLD Identifies Potential Genetic Risk Factors for Advanced Hepatic Fibrosis.” In Hepatology, 60:744A-744A. WILEY-BLACKWELL, 2014.
       Link to Item
    • Guy, Cynthia D., Ayako Suzuki, Manal F. Abdelmalek, James Burchette, and Anna Mae Diehl. “Hedgehog Pathway Targeted by Vitamin E Therapy in NASH.” In Hepatology, 58:249A-249A. WILEY-BLACKWELL, 2013.
       Link to Item
    • Garrett, Melanie E., Cynthia A. Moylan, Jason Gibson, Hyuna Yang, Herbert Pang, Andrew Dellinger, Ayako Suzuki, et al. “Expression QTL analysis of a gene expression signature which predicts advanced non-alcoholic fatty liver disease.” In Hepatology, 56:267A-268A. WILEY-BLACKWELL, 2012.
       Link to Item
    • Suzuki, Ayako, Cynthia D. Guy, Herbert Pang, Alastair D. Smith, Anna Mae Diehl, and Manal F. Abdelmalek. “Impact of Gender and Menopause on Histologic Severity of Inflammation and Injury in patients with Nonalcoholic Fatty Liver Disease.” In Hepatology, 56:901A-901A. WILEY-BLACKWELL, 2012.
       Link to Item
    • Moylan, Cynthia A., Hyuna Yang, Herbert Pang, Andrew Dellinger, Ayako Suzuki, Hans L. Tillmann, Cynthia D. Guy, et al. “Epigenetic Regulation of Gene Expression in NAFLD.” In Gastroenterology, 142:S929–S929. W B SAUNDERS CO-ELSEVIER INC, 2012.
       Link to Item
    • Corbin, Karen D., Melanie D. Spencer, Kerry-Ann da Costa, Wei Sha, Manal F. Abdelmalek, Yiping Pan, Ayako Suzuki, et al. “Genotype-based hierarchical clustering reveals a panel of polymorphisms in one carbon metabolism that are associated with obesity.” In Faseb Journal, Vol. 26, 2012.
       Link to Item
    • Shah, Ketan K., Ayako Suzuki, Jeffrey B. Schwimmer, Aynur Unalp, Cynthia D. Guy, Jean P. Molleston, Peter F. Whitington, Richard Johnson, Anna Mae Diehl, and Manal F. Abdelmalek. “DOSE DEPENDENT ASSOCIATION OF FRUCTOSE CONSUMPTION WITH HYPERURICEMIA AND INSULIN RESISTANCE IN CHILDREN WITH NAFLD.” In Hepatology, 54:1116A-1116A. WILEY-BLACKWELL, 2011.
       Link to Item
    • Moylan, Cynthia A., Andrew Dellinger, Herbert Pang, Ayako Suzuki, Hans L. Tillmann, Daniel Hampton, Yuping Chen, et al. “Modest Alcohol Consumption Attenuates Expression of Fibrosis-Associated Genes in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD).” In Gastroenterology, 140:S914–15. W B SAUNDERS CO-ELSEVIER INC, 2011.
       Link to Item
    • Zdanowicz, Marzena, Ayako Suzuki, Cynthia D. Guy, Jeffrey Schwimmer, Manal F. Abdelmalek, Joel E. Lavine, and Anna Mae Diehl. “Hedgehog Pathway Activation is Associated With Advanced Fibrosis in Pediatric NAFLD.” In Gastroenterology, 140:S987–S987. W B SAUNDERS CO-ELSEVIER INC, 2011.
       Link to Item
    • Corbin, Karen D., Kerry-Ann da Costa, Wei Sha, Manal F. Abdelmalek, Anna Mae Diehl, and Steven H. Zeisel. “Single nucleotide polymorphisms affecting phosphatidylcholine transport are associated with obesity.” In Faseb Journal, Vol. 25. FEDERATION AMER SOC EXP BIOL, 2011.
       Link to Item
    • Abdelmalek, Manal F., Ayako Suzuki, Silke Schmidt, Jacqueline Rimmler, Aynur Unalp, Cynthia D. Guy, Richard Johnson, Michael A. Hauser, and Anna Mae Diehl. “FRUCTOKINASE POLYMORPHISMS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE ARE ASSOCIATED WITH DECREASED URIC ACID AND THE PRESENCE OF HEPATIC FIBROSIS.” In Hepatology, 52:644A-645A. WILEY-BLACKWELL, 2010.
       Link to Item
    • Moylan, Cynthia A., Manal F. Abdelmalek, Herbert Pang, Andrew Dellinger, Steve S. Choi, Alessia Omenetti, Yuping Chen, et al. “SIGNALS FROM THE FIBROTIC LIVER IN PATIENTS WITH NAFLD MAY PROMOTE DIABETES AND OBESITY.” In Hepatology, 52:1049A-1050A. WILEY-BLACKWELL, 2010.
       Link to Item
    • Moylan, Cynthia A., Steve S. Choi, Andrew Dellinger, Herbert Pang, Manal F. Abdelmalek, Daniel Hampton, Yuping Chen, et al. “CONSERVED GENE EXPRESSION PATTERNS IN MYOFIBROBLASTIC MURINE AND HUMAN HEPATIC STELLATE CELLS AND NAFLD PATIENTS WITH LIVER FIBROSIS COMPATIBLE WITH EPITHELIAL-TO-MESENCHYMAL LIKE TRANSITION.” In Hepatology, 52:1286A-1287A. WILEY-BLACKWELL, 2010.
       Link to Item
    • Piercy, Dawn L., Ayako Suzuki, Jing Feng, Yiping Pan, Cynthia D. Guy, Anna Mae Diehl, Ambrose A. Chiang, and Manal F. Abdelmalek. “OBSTRUCTIVE SLEEP APNEA WORSENS HEPATIC INFLAMMATION AND FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.” In Hepatology, 52:631A-631A. WILEY-BLACKWELL, 2010.
       Link to Item
    • Suzuki, Ayako, Martin Binks, Alessia Omenetti, Cynthia D. Guy, Aurora D. Pryor, Yiping Pan, Melissa M. Smith, Anna Mae Diehl, and Manal F. Abdelmalek. “DEPRESSION AND ANXIETY SCORES ARE INDEPENDENTLY ASSOCIATED WITH HISTOLOGIC SEVERITY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.” In Hepatology, 52:626A-626A. WILEY-BLACKWELL, 2010.
       Link to Item
    • Abdelmalek, Manal F., Mariana Lazo, Susanne Bonekamp, Anna Mae Diehl, and Jeanne M. Clark. “INCREASED DIETARY FRUCTOSE IMPAIRS HEPATIC ATP HOMEOSTASIS IN NAFLD.” In Hepatology, 50:777A-777A. JOHN WILEY & SONS INC, 2009.
       Link to Item
    • Suzuki, Ayako, Cynthia D. Guy, Alastair D. Smith, Eric J. DeMaria, Yiping Pan, Melissa M. Smith, Anna Mae Diehl, and Manal F. Abdelmalek. “GENDER AND HORMONAL STATUS ARE ASSOCIATED WITH SEVERITY OF HISTOLOGIC FEATURES AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE.” In Hepatology, 50:772A-773A. JOHN WILEY & SONS INC, 2009.
       Link to Item
    • Wang, Michael, Mark Palmeri, Ned Rouze, Veronica Rotemberg, Barry Moser, Cynthia D. Guy, Anna Mae Diehl, Manal F. Abdelmalek, and Kathryn Nightingale. “NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS WITH QUANTITATIVE ACOUSTIC RADIATION FORCE METHODS.” In Hepatology, 50:743A-744A. JOHN WILEY & SONS INC, 2009.
       Link to Item
    • Suzuki, Ayako, Manal F. Abdelmalek, Cynthia D. Guy, Jeffrey Schwimmer, Joel E. Lavine, A. O. Scheimann, and Anna Mae Diehl. “Sexual Development and Its Influence On Regional Anthropometric Measures and Histologic Features Among Pediatric Patients with NAFLD.” In Gastroenterology, 136:A845–A845. W B SAUNDERS CO-ELSEVIER INC, 2009.
       Link to Item
    • Abdelmalek, Manal F., Keith D. Lindor, Matthew C. Cave, Keith C. Falkner, Rehan Khan, and Craig J. McClain. “HIGH-DOSE BETAINE TREATMENT DOES NOT POSITIVELY INFLUENCE SECOND HIT MECHANISMS IN NASH.” In Hepatology, 48:817A-817A. JOHN WILEY & SONS INC, 2008.
       Link to Item
    • Jung, Youngmi, Cynthia D. Guy, Liu Yang, Manal F. Abdelmalek, and Anna Mae Diehl. “PROGRESSIVE HEDGEHOG PATHWAY ACTIVATION ACCOMPANIES THE DUCTULAR REACTION DURING NAFLD PROGRESSION IN MICE AND HUMANS.” In Hepatology, 48:829A-829A. JOHN WILEY & SONS INC, 2008.
       Link to Item
    • Suzuki, Ayako, Manal F. Abdelmalek, Cynthia D. Guy, and Anna Mae Diehl. “GENDER-SPECIFIC ASSOCIATIONS BETWEEN REGIONAL ANTHROPOMETRIC MEASURES AND HEPATIC FIBROSIS IN PATIENTS WITH NAFLD.” In Hepatology, 48:804A-804A. JOHN WILEY & SONS INC, 2008.
       Link to Item
    • Abdelmalek, Manal F., Schuyler O. Sanderson, Paul Angulo, Chen Liu, Joy Peter, Jill Keach, and Keith D. Lindor. “Betaine for treatment of nonalcoholic steatohepatitis: Results of a randomized placebo controlled study.” In Hepatology, 44:200A-201A. JOHN WILEY & SONS INC, 2006.
       Link to Item
    • Abdelmalek, Manal F., Paul Angulo, Roberta A. Jorgensenh, Pamela B. Sylvestre, and Keith D. Lindor. “Betaine for the treatment of nonalcoholic steatohepatitis: A promising new agent.” In Gastroenterology, 118:A973–A973. Elsevier BV, 2000. https://doi.org/10.1016/s0016-5085(00)86034-5.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.